# Levalbuterol HCL Solution

Notice e4a405df79c0414f8a432f5fcc804792 (solicitation SPE2D221R0116) from DEPT OF DEFENSE, DLA TROOP SUPPORT, posted 2023-07-31, responses due -. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | e4a405df79c0414f8a432f5fcc804792 |
| Solicitation number | SPE2D221R0116 |
| Type | Award Notice |
| Agency | DEPT OF DEFENSE |
| Sub-tier | DEFENSE LOGISTICS AGENCY |
| Office | DLA TROOP SUPPORT |
| Posted | 2023-07-31T15:27:43.000Z |
| Response deadline (UTC) | - |
| Set-aside | - |
| NAICS | 325412 |
| PSC | 6505 |
| Place of performance | Cheshire, GB-ENG, GBR |
| Award | SPE2D222D0146 to Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA, $5,687,207 |

## Description

P00002 SPE2D222D0146 Modification to Invoke Option Year 1. P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) Contract Award for Leavalbuterol HCL Solution SPE2D222D0146

## Sources

- View on SAM.gov: https://sam.gov/opp/e4a405df79c0414f8a432f5fcc804792/view
- Data as of 2026-11-13. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Levalbuterol HCL Solution, SAM.gov contract opportunity e4a405df79c0414f8a432f5fcc804792." samgovapi.io, https://samgovapi.io/opportunity/e4a405df79c0414f8a432f5fcc804792, data as of 2026-11-13. Primary record: https://sam.gov/opp/e4a405df79c0414f8a432f5fcc804792/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/e4a405df79c0414f8a432f5fcc804792
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot